Back to Journals » Cancer Management and Research » Volume 12

Efficiency and Tolerability of Induction and Consolidation Therapy with Arsenic Trioxide/Bortezomib/Ascorbic Acid/Dexamethasone (ABCD) Regimen Compared to Bortezomib/Dexamethasone (BD) Regimen in Newly Diagnosed Myeloma Patients

Total article views   Abstract views HTML views PDF downloads Totals
2,541 Dovepress* 2,146 272+ 428 2,418
PubMed Central* 0 123 43 123
Totals 2,146 395 471 2,541
*Since 20 January 2020
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
2 0 0 0 1 1

View citations on PubMed Central and Google Scholar